Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects

被引：0
|
作者：
Karlsson, P [1 ]
Dencker, E [1 ]
Nyberg, S [1 ]
Mannaert, E [1 ]
Boom, S [1 ]
Talluri, K [1 ]
Rossenu, S [1 ]
Eriksson, B [1 ]
Eerdekens, M [1 ]
Farde, L [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Beerse, Belgium
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S386 / S386
页数：1
相关论文
共 50 条
  • [31] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Blasi, Giuseppe
    Selvaggi, Pierluigi
    Fazio, Leonardo
    Antonucci, Linda Antonella
    Taurisano, Paolo
    Masellis, Rita
    Romano, Raffaella
    Mancini, Marina
    Zhang, Fengyu
    Caforio, Grazia
    Popolizio, Teresa
    Apud, Jose
    Weinberger, Daniel R.
    Bertolino, Alessandro
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (07) : 1600 - 1608
  • [32] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Giuseppe Blasi
    Pierluigi Selvaggi
    Leonardo Fazio
    Linda Antonella Antonucci
    Paolo Taurisano
    Rita Masellis
    Raffaella Romano
    Marina Mancini
    Fengyu Zhang
    Grazia Caforio
    Teresa Popolizio
    Jose Apud
    Daniel R Weinberger
    Alessandro Bertolino
    Neuropsychopharmacology, 2015, 40 : 1600 - 1608
  • [33] Iloperidone -: Antipsychotic dopamine D2 antagonist 5-HT2A antagonist
    不详
    DRUGS OF THE FUTURE, 2001, 26 (01) : 80 - 80
  • [34] A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone
    Mamo, D
    Kapur, S
    Shammi, CM
    Papatheodorou, G
    Mann, S
    Therrien, FO
    Remington, G
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (05): : 818 - 825
  • [35] Pharmacokinetics and Dopamine D2- and Serotonin 5-Ht2a-receptor allocation of paliperidone for healthy test persons: Two open conducted single dose-studies
    Hargarter, Ludger
    Karlsson, P.
    Dencker, E.
    Nyberg, S.
    Mannaert, E.
    Boom, S.
    Talluri, K.
    Rossenu, S.
    Eriksson, B.
    Eerdekens, M.
    Farde, L.
    NERVENARZT, 2007, 78 : 354 - 355
  • [36] Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT2A receptor occupancy as measured by positron emission tomography (PET)
    Hode, Yann
    Benyamina, Amine
    Arbus, Christophe
    Reimold, Matthias
    PSYCHOPHARMACOLOGY, 2011, 217 (03) : 315 - 321
  • [37] Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT2A receptor occupancy as measured by positron emission tomography (PET)
    Yann Hodé
    Amine Benyamina
    Christophe Arbus
    Matthias Reimold
    Psychopharmacology, 2011, 217 : 315 - 321
  • [38] A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)
    Hodé, Y
    Reimold, M
    Demaziéres, A
    Reischl, G
    Bayle, F
    Nuss, P
    Hameg, A
    Dib, M
    Macher, J
    PSYCHOPHARMACOLOGY, 2005, 180 (02) : 377 - 384
  • [39] A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)
    Y. Hodé
    M. Reimold
    A. Demazières
    G. Reischl
    F. Bayle
    P. Nuss
    A. Hameg
    M. Dib
    J. P. Macher
    Psychopharmacology, 2005, 180 : 377 - 384
  • [40] Association analysis of the 5-HT2A receptor and serotonin and dopamine transporter genes with heroin abuse in Bulgarian subjects
    Kaneva, R
    Ivanova, M
    Chorbov, V
    Barakian, G
    Galabova, A
    Nesheva, E
    Kremensky, I
    Todorov, A
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 36 - 36
12345